Tag: Clinical trials

New Orleans was buzzing with excitement as the American Society of Gene and Cell Therapy conference entered its final stretch. Everyone couldn't stop talking...

Pfizer's Braftovi: Extending Survival in Colorectal CancerPfizer has recently announced a groundbreaking development in the world of oncology with their targeted cancer drug, Braftovi,...

Good morning, everyone! We hope you're having a great day. Despite the cloudy skies here at Pharmalot, we're doing well and enjoying the autumn...

The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...

A tough weekend for those supporting MDMA-assisted psychotherapy. First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA...

The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly),...

Good morning everyone, hope you had a restful weekend and are ready to tackle the new week ahead. As we sip on some refreshing...

The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy due to data integrity concerns. These papers were published in 2020 and 2021, and...

The Food and Drug Administration (FDA) recently declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), citing insufficient data to...

Good morning, everyone! It's a new week, and we hope you're ready to tackle whatever challenges come your way. The world keeps spinning, and...

Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in...

Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a...